This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Fava et al¹ found that, of 2 groups with recurrent major depression, the group given cognitive-behavioral therapy (CBT) had significantly lower levels of symptoms and relapse rates after discontinuation of drug therapy than did the clinical treatment group.

While the authors emphasize the benefits of decreasing residual symptoms, with well-being therapy and lifestyle management as perhaps vital to the effectiveness of their CBT package in relapse prevention, this analysis neglected the latest developments in research focused on the precise causes of relapse in recurrent depression.

In particular, Harkness et al² recently found further support for the "stress generation" hypothesis formulated by Hammen,³ which proposes that previously depressed individuals, because of a mixture of maladaptive personality characteristics and disrupted social support networks, generate stressful conditions and events, which in turn cause additional symptoms.

It is the greater frequency of dependent events (ie, events that are caused by the behavior or characteristics . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142
Dazzi et al.
J Psychopharmacol 2002;16:125-131.
ABSTRACT  

Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine
Serra et al.
J Psychopharmacol 2002;16:133-138.
ABSTRACT